[15-Methyl-PGF2alpha (i.m.) treatment in the 2d pregnancy trimester compared to intravenous administration of prostaglandin F2alpha and prostaglandin E2].
D000028:Abortion, Induced; D005260:Female; D006801:Humans; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011458:Prostaglandins E; D011460:Prostaglandins F; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage*
D011458:Prostaglandins E; D011460:Prostaglandins F; D011461:Prostaglandins F, Synthetic
Behandlung mit 15-Methyl-PG-F2alpha (i.m.) im zweiten Schwangerschaftsdrittel im Vergleich zur intravenösen Applikation von Prostaglandin-F2alpha und Prostaglandin E2.